Form 8-K - Current report:
SEC Accession No. 0000939767-21-000005
Filing Date
2021-01-11
Accepted
2021-01-11 16:07:29
Documents
17
Period of Report
2021-01-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K exel-20210110.htm   iXBRL 8-K 38682
2 EX-99.1 a210110corporatepriorities.htm EX-99.1 59460
8 exel-20210110_g1.jpg GRAPHIC 116418
9 image_01.jpg GRAPHIC 116418
  Complete submission text file 0000939767-21-000005.txt   672063

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exel-20210110.xsd EX-101.SCH 2436
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT exel-20210110_cal.xml EX-101.CAL 722
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT exel-20210110_def.xml EX-101.DEF 1659
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exel-20210110_lab.xml EX-101.LAB 24275
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exel-20210110_pre.xml EX-101.PRE 12658
10 EXTRACTED XBRL INSTANCE DOCUMENT exel-20210110_htm.xml XML 10981
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 0101
Type: 8-K | Act: 34 | File No.: 000-30235 | Film No.: 21520883
SIC: 2836 Biological Products, (No Diagnostic Substances)